Kishor Peter Soparkar net worth and biography

Kishor Soparkar Biography and Net Worth

Kishor Peter Soparkar is Adverum’s chief operating officer, responsible for leading the human resources, AD/QC/QA, clinical operations, legal, information technology, and facilities. Mr. Soparkar has 20 years of experience, including corporate development, corporate governance, legal, regulatory, commercial, and public compliance activities, for biotechnology companies as well as at a leading international law firm. Previously, Mr. Soparkar was chief legal officer and head of human resources at Counsyl, Inc., where he also served as corporate secretary and head of compliance. Earlier, Mr. Soparkar was at Jazz Pharmaceuticals for ten years, where he led the legal team’s support of company operations and other business matters, including delivering on numerous debt and equity financings and four landmark transactions. Earlier in his career, Mr. Soparkar worked at Latham & Watkins in London and San Francisco, with a practice spanning international and domestic markets, as well as private and public transactions. He earned a J.D. from New York University and a B.A. in economics and politics from Oberlin College.

What is Kishor Peter Soparkar's net worth?

The estimated net worth of Kishor Peter Soparkar is at least $190,750.20 as of March 15th, 2023. Mr. Soparkar owns 265,891 shares of Adverum Biotechnologies stock worth more than $190,750 as of March 31st. This net worth evaluation does not reflect any other investments that Mr. Soparkar may own. Learn More about Kishor Peter Soparkar's net worth.

How do I contact Kishor Peter Soparkar?

The corporate mailing address for Mr. Soparkar and other Adverum Biotechnologies executives is 800 Saginaw Drive, Redwood City CA, 94063. Adverum Biotechnologies can also be reached via phone at (650) 656-9323 and via email at [email protected] Learn More on Kishor Peter Soparkar's contact information.

Has Kishor Peter Soparkar been buying or selling shares of Adverum Biotechnologies?

During the last quarter, Kishor Peter Soparkar has sold $10,420.80 of Adverum Biotechnologies stock. Most recently, Peter Soparkar sold 13,360 shares of the business's stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $0.78, for a transaction totalling $10,420.80. Following the completion of the sale, the chief operating officer now directly owns 265,891 shares of the company's stock, valued at $207,394.98. Learn More on Kishor Peter Soparkar's trading history.

Who are Adverum Biotechnologies' active insiders?

Adverum Biotechnologies' insider roster includes Julie Clark (Insider), Laurent Fischer (CEO), James Scopa (Director), and Kishor Soparkar (Insider). Learn More on Adverum Biotechnologies' active insiders.

Are insiders buying or selling shares of Adverum Biotechnologies?

During the last year, Adverum Biotechnologies insiders bought shares 6 times. They purchased a total of 116,925 shares worth more than $111,944.50. During the last year, insiders at the biotechnology company sold shares 5 times. They sold a total of 107,252 shares worth more than $96,809.22. The most recent insider tranaction occured on March, 15th when insider Brigit Riley sold 7,299 shares worth more than $5,693.22. Insiders at Adverum Biotechnologies own 3.3% of the company. Learn More about insider trades at Adverum Biotechnologies.

Information on this page was last updated on 3/15/2023.

Kishor Peter Soparkar Insider Trading History at Adverum Biotechnologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2023Sell13,360$0.78$10,420.80265,891View SEC Filing Icon  
4/19/2022Buy21,925$1.14$24,994.50280,556View SEC Filing Icon  
12/8/2021Buy25,000$1.91$47,750.00View SEC Filing Icon  
8/17/2020Buy7,692$13.00$99,996.007,692View SEC Filing Icon  
See Full Table

Kishor Peter Soparkar Buying and Selling Activity at Adverum Biotechnologies

This chart shows Peter Soparkar's buying and selling at Adverum Biotechnologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adverum Biotechnologies Company Overview

Adverum Biotechnologies logo
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Read More

Today's Range

Now: $0.72
Low: $0.72
High: $0.76

50 Day Range

MA: $0.72
Low: $0.62
High: $0.85

2 Week Range

Now: $0.72
Low: $0.53
High: $1.82


109,783 shs

Average Volume

422,737 shs

Market Capitalization

$71.55 million

P/E Ratio


Dividend Yield